354
edits
Turnbaugh: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
no edit summary
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Template:Turnbaugh}} | {{Template:Turnbaugh}} | ||
<div style="font-size: medium; width: 750px;"> | <div style="font-size: medium; width: 750px;"> | ||
[[Image:HomePageImage2.jpg|400px||right|]] | [[Image:HomePageImage2.jpg|400px||right|]] | ||
We have recently moved to UCSF, please see our updated page #REDIRECT [[[http://turnbaughlab.ucsf.edu HERE]]] | |||
The human ‘metagenome’ is a composite of <i>Homo sapiens</i> genes and the genomes of the trillions of microbes that colonize our adult bodies (the ‘microbiome’). Our largest collection of microbes resides in the gut, where an estimated 10-100 trillion organisms reside (the gut microbiota). The gut microbiome extends human metabolism by enabling the degradation of otherwise indigestible components of our diet, and by influencing the activity, toxicity, and bioavailability of therapeutics. These microbial biotransformations can have important consequences for host health and disease, including contributing to metabolic syndrome, inflammatory bowel disease, and cancer. | The human ‘metagenome’ is a composite of <i>Homo sapiens</i> genes and the genomes of the trillions of microbes that colonize our adult bodies (the ‘microbiome’). Our largest collection of microbes resides in the gut, where an estimated 10-100 trillion organisms reside (the gut microbiota). The gut microbiome extends human metabolism by enabling the degradation of otherwise indigestible components of our diet, and by influencing the activity, toxicity, and bioavailability of therapeutics. These microbial biotransformations can have important consequences for host health and disease, including contributing to metabolic syndrome, inflammatory bowel disease, and cancer. | ||
